COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #167
Source   PDF   Share   Tweet
See all 181 studies
Late treatment study
Núñez-Gil et al., Intern. Emerg. Med., doi:10.1007/s11739-020-02543-5 (Peer Reviewed)
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Retrospective database study of 1,021 patients in Ecuador, Germany, Italy, and Spain, showing HC Q propensity score adjusted mortality odds ratio aOR 0.88, p=0.005.
death, ↓7.9%, p=0.005
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.